Souhaitez-vous accéder aux communiqués récents ?

PHOENIX, May 14, 2025 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the fourth quarter and fiscal year ended March 29, 2025 on Thursday, May 22, 2025 after the...

CICERO, Ill., May 13, 2025 (GLOBE NEWSWIRE) --  Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...

Agios Pharmaceuticals today announced that its management team is scheduled to present at the 2025 RBC Capital Markets Global Healthcare Conference

The Beauty Health Company's reported first quarter 2025 revenue and adjusted EBITDA exceed guidance, driven by gross profit growth and cost management.

First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024,...

HOUSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) will announce its 2025 first quarter results on May 14, 2025, before...

YAVNE, Israel, May 05, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will report...

Agios Pharmaceuticals today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference

Agios Pharmaceuticals, Inc. today reported business highlights and financial results for the first quarter ended March 31, 2025.